Search Results for: Influenza

1761 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
HSP90B1 and POLR2E heat shock protein 90kDa beta (Grp94), member 1 polymerase (RNA) II (DNA directed) polypeptide E, 25kDa
  • Toll-Like Receptors Cascades
  • Trafficking and processing of endosomal TLR
  • Scavenging by Class A Receptors
  • ATF6-alpha activates chaperones
  • ATF6-alpha activates chaperone genes
  • Unfolded Protein Response (UPR)
  • Innate Immune System
  • RNA Polymerase II Promoter Escape
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Chain Elongation
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Regulatory RNA pathways
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • Dual incision reaction in TC-NER
  • Influenza Life Cycle
  • RNA Polymerase III Transcription Termination
  • HIV elongation arrest and recovery
  • NoRC negatively regulates rRNA expression
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase III Chain Elongation
  • RNA Polymerase III Transcription
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • MicroRNA (miRNA) biogenesis
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase III Abortive And Retractive Initiation
  • Transcription of the HIV genome
  • Nucleotide Excision Repair
  • PIWI-interacting RNA (piRNA) biogenesis
  • mRNA Splicing
  • RNA Polymerase III Transcription Initiation From Type 3 Promoter
  • RNA Polymerase II Transcription
  • RNA Polymerase I Transcription Initiation
  • RNA Polymerase I Promoter Clearance
  • HIV Infection
  • Formation of the Early Elongation Complex
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Transcriptional regulation of pluripotent stem cells
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Innate Immune System
  • RNA Polymerase III Transcription Initiation
  • Transcriptional regulation by small RNAs
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • RNA Polymerase I Transcription
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase I Transcription Termination
  • Cytosolic sensors of pathogen-associated DNA
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • Transcription-coupled NER (TC-NER)
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Pausing and recovery of HIV elongation
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Elongation
  • Rifabutin
  • 2-Chlorodideoxyadenosine
  • 1-Methoxy-2-(2-Methoxyethoxy)Ethane
  • Adenosine-5\'-Diphosphate
  • N-Ethyl-5\'-Carboxamido Adenosine
  • Radicicol
  • METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE
  • 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE
TNNC1 and POLR2G troponin C type 1 (slow) polymerase (RNA) II (DNA directed) polypeptide G
  • Striated Muscle Contraction
  • RNA Polymerase II Promoter Escape
  • mRNA Splicing
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • PIWI-interacting RNA (piRNA) biogenesis
  • Nucleotide Excision Repair
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Regulatory RNA pathways
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • Dual incision reaction in TC-NER
  • Influenza Life Cycle
  • HIV elongation arrest and recovery
  • HIV Life Cycle
  • HIV Transcription Initiation
  • Influenza Viral RNA Transcription and Replication
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Transcriptional regulation of pluripotent stem cells
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Transcriptional regulation by small RNAs
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • MicroRNA (miRNA) biogenesis
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Transcription-coupled NER (TC-NER)
  • Viral Messenger RNA Synthesis
  • Formation of the HIV-1 Early Elongation Complex
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
  • Trifluoperazine
  • Levosimendan
  • Felodipine
  • Bepridil
  • Calcium
  • Dihydroxyaluminium
  • 5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One
  • N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide
GRIA1 and CANX glutamate receptor, ionotropic, AMPA 1 calnexin
  • Trafficking of GluR2-containing AMPA receptors
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • Activation of AMPA receptors
  • Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity
  • Trafficking of AMPA receptors
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Transmission across Chemical Synapses
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • L-Glutamic Acid
  • Enflurane
  • Isoflurane
  • Methoxyflurane
  • Desflurane
  • Sevoflurane
  • Perampanel
  • Antihemophilic Factor
  • Tenecteplase
BLVRB and RPL31 biliverdin reductase B ribosomal protein L31
  • Metabolism of porphyrins
  • Heme degradation
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Riboflavin
  • NADH
  • Biliverdine Ix Alpha
  • Riboflavin Monophosphate
  • 2\'-Monophosphoadenosine 5\'-Diphosphoribose
  • 7,8-dimethylalloxazine
  • Mesobiliverdin Iv Alpha
CDK5 and RPL34 cyclin-dependent kinase 5 ribosomal protein L34
  • Signaling by GPCR
  • Axon guidance
  • Semaphorin interactions
  • Opioid Signalling
  • DARPP-32 events
  • CRMPs in Sema3A signaling
  • Factors involved in megakaryocyte development and platelet production
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Indirubin-3\'-Monoxime
  • Olomoucine
  • Hymenialdisine
  • SU9516
  • Flavopiridol
  • Alsterpaullone
  • 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE
PDGFRB and EIF2AK2 platelet-derived growth factor receptor, beta polypeptide eukaryotic translation initiation factor 2-alpha kinase 2
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • PIP3 activates AKT signaling
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Innate Immune System
  • Signaling by PDGF
  • Signalling by NGF
  • DAP12 interactions
  • GAB1 signalosome
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by FGFR
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Inhibition of PKR
  • Cytokine Signaling in Immune system
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • NS1 Mediated Effects on Host Pathways
  • Antiviral mechanism by IFN-stimulated genes
  • Becaplermin
  • Sorafenib
  • Imatinib
  • Dasatinib
  • Sunitinib
  • Pazopanib
  • Regorafenib
LHCGR and CANX luteinizing hormone/choriogonadotropin receptor calnexin
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • G alpha (s) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Hormone ligand-binding receptors
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Goserelin
  • Menotropins
  • Lutropin alfa
  • Cetrorelix
  • Choriogonadotropin alfa
  • Buserelin
  • Antihemophilic Factor
  • Tenecteplase
ALDH2 and RPL13A aldehyde dehydrogenase 2 family (mitochondrial) ribosomal protein L13a
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Metabolic disorders of biological oxidation enzymes
  • Ethanol oxidation
  • Phase 1 - Functionalization of compounds
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Biological oxidations
  • Serotonin clearance from the synaptic cleft
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Metabolism of serotonin
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • Defective CYP1B1 causes Glaucoma
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Neurotransmitter Clearance In The Synaptic Cleft
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Transmission across Chemical Synapses
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • NADH
  • Guanidine
  • Disulfiram
  • Nicotinamide-Adenine-Dinucleotide
  • Daidzin
  • Crotonaldehyde
PLAT and CALR plasminogen activator, tissue calreticulin
  • Signaling by PDGF
  • Dissolution of Fibrin Clot
  • Orphan transporters
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Urokinase
  • Aminocaproic Acid
  • Ibuprofen
  • Iloprost
  • 6-Amino Hexanoic Acid
  • 5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID
CDK1 and NUP210 cyclin-dependent kinase 1 nucleoporin 210kDa
  • Phosphorylation of the APC/C
  • Signaling by FGFR in disease
  • Phosphorylation of Emi1
  • Signaling by EGFRvIII in Cancer
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Toll Like Receptor 5 (TLR5) Cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • MyD88 dependent cascade initiated on endosome
  • SOS-mediated signalling
  • Mitotic G1-G1/S phases
  • SHC-mediated signalling
  • Recruitment of mitotic centrosome proteins and complexes
  • TRIF-mediated TLR3/TLR4 signaling
  • ERK1 activation
  • Nuclear Pore Complex (NPC) Disassembly
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • ERK1 activation
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Signaling by VEGF
  • Resolution of Sister Chromatid Cohesion
  • Downstream signal transduction
  • Signalling to RAS
  • Toll Like Receptor 3 (TLR3) Cascade
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Interleukin-2 signaling
  • Mitotic G2-G2/M phases
  • Frs2-mediated activation
  • MASTL Facilitates Mitotic Progression
  • Axon guidance
  • IRS-mediated signalling
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • Activated TLR4 signalling
  • VEGFR2 mediated cell proliferation
  • GRB2 events in ERBB2 signaling
  • Cyclin A/B1 associated events during G2/M transition
  • Loss of Nlp from mitotic centrosomes
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • NCAM signaling for neurite out-growth
  • RAF/MAP kinase cascade
  • Signalling to p38 via RIT and RIN
  • Innate Immune System
  • Condensation of Prometaphase Chromosomes
  • Signaling by Insulin receptor
  • E2F mediated regulation of DNA replication
  • Insulin receptor signalling cascade
  • Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
  • G0 and Early G1
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • SHC-related events
  • Signaling by FGFR
  • ARMS-mediated activation
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • E2F-enabled inhibition of pre-replication complex formation
  • Regulation of mitotic cell cycle
  • Cell Cycle Checkpoints
  • Signaling by GPCR
  • G2/M Checkpoints
  • Mitotic Prophase
  • Golgi Cisternae Pericentriolar Stack Reorganization
  • FCERI mediated MAPK activation
  • Regulation of PLK1 Activity at G2/M Transition
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • G1/S Transition
  • G1/S-Specific Transcription
  • Toll Like Receptor 9 (TLR9) Cascade
  • G2/M DNA replication checkpoint
  • Signaling by PDGF
  • DAP12 interactions
  • SHC-related events triggered by IGF1R
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • APC/C-mediated degradation of cell cycle proteins
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • SHC1 events in ERBB4 signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Condensation of Prophase Chromosomes
  • Signaling by Leptin
  • Signalling to ERKs
  • Mitotic Prometaphase
  • Prolonged ERK activation events
  • Organelle biogenesis and maintenance
  • ERK activation
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Activation of NIMA Kinases NEK9, NEK6, NEK7
  • Nuclear Envelope Breakdown
  • IGF1R signaling cascade
  • Recruitment of NuMA to mitotic centrosomes
  • Cyclin B2 mediated events
  • Toll Like Receptor TLR6:TLR2 Cascade
  • M Phase
  • IRS-related events triggered by IGF1R
  • MyD88 cascade initiated on plasma membrane
  • ERK activation
  • Downstream signaling of activated FGFR
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • Signalling by NGF
  • SOS-mediated signalling
  • G2/M DNA damage checkpoint
  • MAP kinase activation in TLR cascade
  • SHC-mediated signalling
  • Depolymerisation of the Nuclear Lamina
  • Assembly of the primary cilium
  • Cytokine Signaling in Immune system
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • MyD88-independent cascade
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • SHC1 events in EGFR signaling
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • FRS2-mediated cascade
  • IRS-mediated signalling
  • Centrosome maturation
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
  • Indirubin-3\'-Monoxime
  • Olomoucine
  • Hymenialdisine
  • SU9516
  • Flavopiridol
  • Alsterpaullone
FGF2 and RPS19 fibroblast growth factor 2 (basic) ribosomal protein S19
  • Signaling by the B Cell Receptor (BCR)
  • Phospholipase C-mediated cascade
  • Signaling by FGFR in disease
  • SHC-mediated cascade
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Signaling by FGFR2 mutants
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • Signaling by activated point mutants of FGFR1
  • Signaling by FGFR1 mutants
  • PI3K Cascade
  • Negative regulation of FGFR signaling
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • Activated point mutants of FGFR2
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • FGFR4 ligand binding and activation
  • Syndecan interactions
  • Signaling by EGFR
  • Signaling by FGFR3 mutants
  • Downstream signal transduction
  • Signaling by activated point mutants of FGFR3
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by FGFR mutants
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • IRS-related events triggered by IGF1R
  • Transcriptional regulation of pluripotent stem cells
  • PI3K events in ERBB2 signaling
  • FGFR1b ligand binding and activation
  • Downstream signaling of activated FGFR
  • FGFR3c ligand binding and activation
  • FGFR1c ligand binding and activation
  • FGFR2c ligand binding and activation
  • FGFR ligand binding and activation
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Signaling by Insulin receptor
  • Innate Immune System
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • IRS-related events
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Non-integrin membrane-ECM interactions
  • FGFR3 ligand binding and activation
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • FGFR2 ligand binding and activation
  • FRS2-mediated cascade
  • IRS-mediated signalling
  • FGFR1 ligand binding and activation
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • PI3K Cascade
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Sucralfate
  • Pentosan Polysulfate
  • Sirolimus
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
FGF2 and RPL6 fibroblast growth factor 2 (basic) ribosomal protein L6
  • Signaling by the B Cell Receptor (BCR)
  • Phospholipase C-mediated cascade
  • Signaling by FGFR in disease
  • SHC-mediated cascade
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Signaling by FGFR2 mutants
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • Signaling by activated point mutants of FGFR1
  • Signaling by FGFR1 mutants
  • PI3K Cascade
  • Negative regulation of FGFR signaling
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • Activated point mutants of FGFR2
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • FGFR4 ligand binding and activation
  • Syndecan interactions
  • Signaling by EGFR
  • Signaling by FGFR3 mutants
  • Downstream signal transduction
  • Signaling by activated point mutants of FGFR3
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by FGFR mutants
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • IRS-related events triggered by IGF1R
  • Transcriptional regulation of pluripotent stem cells
  • PI3K events in ERBB2 signaling
  • FGFR1b ligand binding and activation
  • Downstream signaling of activated FGFR
  • FGFR3c ligand binding and activation
  • FGFR1c ligand binding and activation
  • FGFR2c ligand binding and activation
  • FGFR ligand binding and activation
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Signaling by Insulin receptor
  • Innate Immune System
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • IRS-related events
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Non-integrin membrane-ECM interactions
  • FGFR3 ligand binding and activation
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • FGFR2 ligand binding and activation
  • FRS2-mediated cascade
  • IRS-mediated signalling
  • FGFR1 ligand binding and activation
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • PI3K Cascade
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Sucralfate
  • Pentosan Polysulfate
  • Sirolimus
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
TUBA1A and KPNB1 tubulin, alpha 1a karyopherin (importin) beta 1
  • Transport of connexons to the plasma membrane
  • Mitotic Prometaphase
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Hedgehog 'off' state
  • Separation of Sister Chromatids
  • Translocation of GLUT4 to the plasma membrane
  • L1CAM interactions
  • G2/M Transition
  • Mitotic Anaphase
  • Recycling pathway of L1
  • Recruitment of NuMA to mitotic centrosomes
  • Regulation of PLK1 Activity at G2/M Transition
  • Formation of tubulin folding intermediates by CCT/TriC
  • Intraflagellar transport
  • M Phase
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding
  • Post-chaperonin tubulin folding pathway
  • Loss of Nlp from mitotic centrosomes
  • Gap junction trafficking and regulation
  • MHC class II antigen presentation
  • Recruitment of mitotic centrosome proteins and complexes
  • Protein folding
  • Gap junction assembly
  • Gap junction trafficking
  • Kinesins
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Assembly of the primary cilium
  • Factors involved in megakaryocyte development and platelet production
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Resolution of Sister Chromatid Cohesion
  • Chaperonin-mediated protein folding
  • Signaling by Hedgehog
  • Centrosome maturation
  • Mitotic G2-G2/M phases
  • Mitotic Metaphase and Anaphase
  • Adaptive Immune System
  • Metabolism of lipids and lipoproteins
  • ISG15 antiviral mechanism
  • Nuclear import of Rev protein
  • HIV Infection
  • Interferon Signaling
  • Apoptotic execution phase
  • Host Interactions of HIV factors
  • Cytokine Signaling in Immune system
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Albendazole
  • Vinblastine
  • Mebendazole
  • Epothilone D
  • Epothilone B
  • 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE
SYK and RPS10 spleen tyrosine kinase ribosomal protein S10
  • Signaling by the B Cell Receptor (BCR)
  • FCERI mediated MAPK activation
  • Platelet Aggregation (Plug Formation)
  • DAP12 signaling
  • Regulation of signaling by CBL
  • Role of phospholipids in phagocytosis
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • FCGR activation
  • Regulation of actin dynamics for phagocytic cup formation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • DAP12 interactions
  • Integrin alphaIIb beta3 signaling
  • Cytokine Signaling in Immune system
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Signaling by Interleukins
  • Fc epsilon receptor (FCERI) signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • FCERI mediated Ca+2 mobilization
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Staurosporine
  • N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide
  • 6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one
  • 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide
  • 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide
  • Ellagic Acid
FSHR and CANX follicle stimulating hormone receptor calnexin
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • G alpha (s) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Hormone ligand-binding receptors
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Menotropins
  • Follitropin beta
  • Urofollitropin
  • Choriogonadotropin alfa
  • Suramin
  • Antihemophilic Factor
  • Tenecteplase
FSHR and UBA52 follicle stimulating hormone receptor ubiquitin A-52 residue ribosomal protein fusion product 1
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • G alpha (s) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Hormone ligand-binding receptors
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Loss of Function of TGFBR2 in Cancer
  • NF-kB is activated and signals survival
  • Hedgehog 'off' state
  • Signaling by FGFR in disease
  • Influenza Life Cycle
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Glucose metabolism
  • Signaling by NOTCH1
  • Signaling by NOTCH2
  • Toll Like Receptor 5 (TLR5) Cascade
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • Stabilization of p53
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Downregulation of ERBB2:ERBB3 signaling
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • Signaling by NOTCH
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • Spry regulation of FGF signaling
  • Influenza Infection
  • Signaling by NOTCH
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Regulation of innate immune responses to cytosolic DNA
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Toll Like Receptor 3 (TLR3) Cascade
  • Metabolism of carbohydrates
  • CDK-mediated phosphorylation and removal of Cdc6
  • Cellular response to hypoxia
  • Hedgehog ligand biogenesis
  • p75NTR recruits signalling complexes
  • Fanconi Anemia pathway
  • Separation of Sister Chromatids
  • APC truncation mutants have impaired AXIN binding
  • HIV Infection
  • Peptide chain elongation
  • Assembly of the pre-replicative complex
  • Activated TLR4 signalling
  • Synthesis And Processing Of GAG, GAGPOL Polyproteins
  • S37 mutants of beta-catenin aren't phosphorylated
  • p53-Dependent G1 DNA Damage Response
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • regulation of FZD by ubiquitination
  • Signaling by NOTCH1
  • p53-Independent DNA Damage Response
  • MyD88:Mal cascade initiated on plasma membrane
  • Stimuli-sensing channels
  • p53-Independent G1/S DNA damage checkpoint
  • Membrane binding and targetting of GAG proteins
  • G1/S DNA Damage Checkpoints
  • Downregulation of ERBB4 signaling
  • Vpu mediated degradation of CD4
  • Cell death signalling via NRAGE, NRIF and NADE
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Eukaryotic Translation Termination
  • M/G1 Transition
  • p75 NTR receptor-mediated signalling
  • Signaling by FGFR
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by NOTCH1 in Cancer
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Degradation of GLI1 by the proteasome
  • Cell Cycle Checkpoints
  • degradation of DVL
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Vif-mediated degradation of APOBEC3G
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Downregulation of TGF-beta receptor signaling
  • truncated APC mutants destabilize the destruction complex
  • Cyclin E associated events during G1/S transition
  • TGF-beta receptor signaling activates SMADs
  • Regulation of PLK1 Activity at G2/M Transition
  • FCERI mediated NF-kB activation
  • Generic Transcription Pathway
  • Regulation of the Fanconi anemia pathway
  • G1/S Transition
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Toll Like Receptor 9 (TLR9) Cascade
  • IRAK1 recruits IKK complex
  • truncations of AMER1 destabilize the destruction complex
  • Negative regulation of FGFR signaling
  • EGFR downregulation
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • Translation
  • IRAK2 mediated activation of TAK1 complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Host Interactions of HIV factors
  • Signaling by ERBB4
  • Antiviral mechanism by IFN-stimulated genes
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Fc epsilon receptor (FCERI) signaling
  • Interleukin-3, 5 and GM-CSF signaling
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • APC truncation mutants are not K63 polyubiquitinated
  • M Phase
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • HIV Life Cycle
  • Budding and maturation of HIV virion
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • IKK complex recruitment mediated by RIP1
  • MAP kinase activation in TLR cascade
  • Regulation of DNA replication
  • Cytokine Signaling in Immune system
  • MyD88-independent cascade
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Viral mRNA Translation
  • Cell Cycle, Mitotic
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Oxidative Stress Induced Senescence
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
  • Formation of a pool of free 40S subunits
  • TRAF6 mediated induction of TAK1 complex
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • Negative regulators of RIG-I/MDA5 signaling
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • Cellular Senescence
  • T41 mutants of beta-catenin aren't phosphorylated
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by EGFRvIII in Cancer
  • Downstream signaling events of B Cell Receptor (BCR)
  • Assembly Of The HIV Virion
  • Degradation of beta-catenin by the destruction complex
  • Influenza Viral RNA Transcription and Replication
  • NOD1/2 Signaling Pathway
  • MyD88 dependent cascade initiated on endosome
  • Glycogen storage diseases
  • Cap-dependent Translation Initiation
  • Mitotic G1-G1/S phases
  • activated TAK1 mediates p38 MAPK activation
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • TRIF-mediated TLR3/TLR4 signaling
  • DNA Replication Pre-Initiation
  • Senescence-Associated Secretory Phenotype (SASP)
  • S45 mutants of beta-catenin aren't phosphorylated
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • TGFBR1 KD Mutants in Cancer
  • Regulation of APC/C activators between G1/S and early anaphase
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Late Phase of HIV Life Cycle
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • NOTCH2 Activation and Transmission of Signal to the Nucleus
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • TCR signaling
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Interleukin-1 signaling
  • Eukaryotic Translation Elongation
  • PCP/CE pathway
  • Mitotic G2-G2/M phases
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Adaptive Immune System
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Ubiquitin-dependent degradation of Cyclin D
  • G2/M Transition
  • Oncogene Induced Senescence
  • TGFBR1 LBD Mutants in Cancer
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • Ion channel transport
  • Eukaryotic Translation Initiation
  • p75NTR signals via NF-kB
  • Regulation of signaling by CBL
  • Disease
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Signal Transduction
  • Innate Immune System
  • Nonsense-Mediated Decay (NMD)
  • Synthesis of DNA
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • G1 Phase
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Ubiquitin-dependent degradation of Cyclin D1
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Toll-Like Receptors Cascades
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Cyclin D associated events in G1
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Regulation of mitotic cell cycle
  • Signaling by Hedgehog
  • Association of licensing factors with the pre-replicative complex
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • TCF7L2 mutants don't bind CTBP
  • p53-Dependent G1/S DNA damage checkpoint
  • Signaling by Wnt
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • APC/C:Cdc20 mediated degradation of Securin
  • AUF1 (hnRNP D0) destabilizes mRNA
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • IRAK1 recruits IKK complex
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • RNF mutants show enhanced WNT signaling and proliferation
  • Myoclonic epilepsy of Lafora
  • Signaling by NOTCH1 in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • IRAK2 mediated activation of TAK1 complex
  • SRP-dependent cotranslational protein targeting to membrane
  • Loss of Function of SMAD4 in Cancer
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Signaling by ERBB2
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by EGFR
  • Signaling by Interleukins
  • Glycogen synthesis
  • NRIF signals cell death from the nucleus
  • Toll Like Receptor 4 (TLR4) Cascade
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by EGFR in Cancer
  • SCF(Skp2)-mediated degradation of p27/p21
  • Cyclin A:Cdk2-associated events at S phase entry
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Mitotic Metaphase and Anaphase
  • Downstream TCR signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • deactivation of the beta-catenin transactivating complex
  • Toll Like Receptor TLR6:TLR2 Cascade
  • MyD88 cascade initiated on plasma membrane
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Signalling by NGF
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Cytosolic sensors of pathogen-associated DNA
  • beta-catenin independent WNT signaling
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Orc1 removal from chromatin
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Signaling by TGF-beta Receptor Complex
  • CDT1 association with the CDC6:ORC:origin complex
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • SMAD4 MH2 Domain Mutants in Cancer
  • Menotropins
  • Follitropin beta
  • Urofollitropin
  • Choriogonadotropin alfa
  • Suramin
FSHR and RPS27A follicle stimulating hormone receptor ribosomal protein S27a
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • G alpha (s) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Hormone ligand-binding receptors
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Loss of Function of TGFBR2 in Cancer
  • NF-kB is activated and signals survival
  • Hedgehog 'off' state
  • Signaling by FGFR in disease
  • Influenza Life Cycle
  • Glucose metabolism
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Signaling by NOTCH1
  • Signaling by NOTCH2
  • Toll Like Receptor 5 (TLR5) Cascade
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • Stabilization of p53
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Downregulation of ERBB2:ERBB3 signaling
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • Signaling by NOTCH
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • Spry regulation of FGF signaling
  • Influenza Infection
  • Signaling by NOTCH
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Regulation of innate immune responses to cytosolic DNA
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Toll Like Receptor 3 (TLR3) Cascade
  • Metabolism of carbohydrates
  • CDK-mediated phosphorylation and removal of Cdc6
  • Cellular response to hypoxia
  • Hedgehog ligand biogenesis
  • p75NTR recruits signalling complexes
  • Fanconi Anemia pathway
  • Separation of Sister Chromatids
  • APC truncation mutants have impaired AXIN binding
  • HIV Infection
  • Peptide chain elongation
  • Assembly of the pre-replicative complex
  • Activated TLR4 signalling
  • Synthesis And Processing Of GAG, GAGPOL Polyproteins
  • S37 mutants of beta-catenin aren't phosphorylated
  • p53-Dependent G1 DNA Damage Response
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • regulation of FZD by ubiquitination
  • Signaling by NOTCH1
  • p53-Independent DNA Damage Response
  • MyD88:Mal cascade initiated on plasma membrane
  • Stimuli-sensing channels
  • p53-Independent G1/S DNA damage checkpoint
  • Membrane binding and targetting of GAG proteins
  • G1/S DNA Damage Checkpoints
  • Downregulation of ERBB4 signaling
  • Vpu mediated degradation of CD4
  • Cell death signalling via NRAGE, NRIF and NADE
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Eukaryotic Translation Termination
  • M/G1 Transition
  • p75 NTR receptor-mediated signalling
  • Signaling by FGFR
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by NOTCH1 in Cancer
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Degradation of GLI1 by the proteasome
  • Cell Cycle Checkpoints
  • degradation of DVL
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Translation initiation complex formation
  • Vif-mediated degradation of APOBEC3G
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Downregulation of TGF-beta receptor signaling
  • truncated APC mutants destabilize the destruction complex
  • Cyclin E associated events during G1/S transition
  • TGF-beta receptor signaling activates SMADs
  • Regulation of PLK1 Activity at G2/M Transition
  • FCERI mediated NF-kB activation
  • Generic Transcription Pathway
  • Regulation of the Fanconi anemia pathway
  • G1/S Transition
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Toll Like Receptor 9 (TLR9) Cascade
  • IRAK1 recruits IKK complex
  • truncations of AMER1 destabilize the destruction complex
  • Negative regulation of FGFR signaling
  • EGFR downregulation
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • Translation
  • IRAK2 mediated activation of TAK1 complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Host Interactions of HIV factors
  • Signaling by ERBB4
  • Antiviral mechanism by IFN-stimulated genes
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Fc epsilon receptor (FCERI) signaling
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Interleukin-3, 5 and GM-CSF signaling
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • APC truncation mutants are not K63 polyubiquitinated
  • M Phase
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • HIV Life Cycle
  • Budding and maturation of HIV virion
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • IKK complex recruitment mediated by RIP1
  • MAP kinase activation in TLR cascade
  • Regulation of DNA replication
  • Cytokine Signaling in Immune system
  • MyD88-independent cascade
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Viral mRNA Translation
  • Cell Cycle, Mitotic
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Oxidative Stress Induced Senescence
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
  • Formation of a pool of free 40S subunits
  • TRAF6 mediated induction of TAK1 complex
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • Negative regulators of RIG-I/MDA5 signaling
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • Cellular Senescence
  • T41 mutants of beta-catenin aren't phosphorylated
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by EGFRvIII in Cancer
  • Downstream signaling events of B Cell Receptor (BCR)
  • Assembly Of The HIV Virion
  • Degradation of beta-catenin by the destruction complex
  • Influenza Viral RNA Transcription and Replication
  • NOD1/2 Signaling Pathway
  • MyD88 dependent cascade initiated on endosome
  • Glycogen storage diseases
  • Cap-dependent Translation Initiation
  • Mitotic G1-G1/S phases
  • activated TAK1 mediates p38 MAPK activation
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • TRIF-mediated TLR3/TLR4 signaling
  • DNA Replication Pre-Initiation
  • Senescence-Associated Secretory Phenotype (SASP)
  • S45 mutants of beta-catenin aren't phosphorylated
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • TGFBR1 KD Mutants in Cancer
  • Regulation of APC/C activators between G1/S and early anaphase
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Late Phase of HIV Life Cycle
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • NOTCH2 Activation and Transmission of Signal to the Nucleus
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • TCR signaling
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Interleukin-1 signaling
  • Eukaryotic Translation Elongation
  • PCP/CE pathway
  • Mitotic G2-G2/M phases
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Adaptive Immune System
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Ubiquitin-dependent degradation of Cyclin D
  • G2/M Transition
  • Oncogene Induced Senescence
  • TGFBR1 LBD Mutants in Cancer
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • Ion channel transport
  • Eukaryotic Translation Initiation
  • p75NTR signals via NF-kB
  • Regulation of signaling by CBL
  • Disease
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Signal Transduction
  • Innate Immune System
  • Nonsense-Mediated Decay (NMD)
  • Synthesis of DNA
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • G1 Phase
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Ubiquitin-dependent degradation of Cyclin D1
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Toll-Like Receptors Cascades
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Cyclin D associated events in G1
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Regulation of mitotic cell cycle
  • Signaling by Hedgehog
  • Association of licensing factors with the pre-replicative complex
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • TCF7L2 mutants don't bind CTBP
  • p53-Dependent G1/S DNA damage checkpoint
  • Signaling by Wnt
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • APC/C:Cdc20 mediated degradation of Securin
  • AUF1 (hnRNP D0) destabilizes mRNA
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • IRAK1 recruits IKK complex
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • RNF mutants show enhanced WNT signaling and proliferation
  • Myoclonic epilepsy of Lafora
  • Signaling by NOTCH1 in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • IRAK2 mediated activation of TAK1 complex
  • SRP-dependent cotranslational protein targeting to membrane
  • Loss of Function of SMAD4 in Cancer
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Signaling by ERBB2
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by EGFR
  • Signaling by Interleukins
  • Glycogen synthesis
  • NRIF signals cell death from the nucleus
  • Toll Like Receptor 4 (TLR4) Cascade
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by EGFR in Cancer
  • SCF(Skp2)-mediated degradation of p27/p21
  • Cyclin A:Cdk2-associated events at S phase entry
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Mitotic Metaphase and Anaphase
  • Downstream TCR signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • deactivation of the beta-catenin transactivating complex
  • Toll Like Receptor TLR6:TLR2 Cascade
  • MyD88 cascade initiated on plasma membrane
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Signalling by NGF
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Cytosolic sensors of pathogen-associated DNA
  • beta-catenin independent WNT signaling
  • Ribosomal scanning and start codon recognition
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Orc1 removal from chromatin
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Signaling by TGF-beta Receptor Complex
  • CDT1 association with the CDC6:ORC:origin complex
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • SMAD4 MH2 Domain Mutants in Cancer
  • Menotropins
  • Follitropin beta
  • Urofollitropin
  • Choriogonadotropin alfa
  • Suramin
BCL2 and HSPA1A B-cell CLL/lymphoma 2 heat shock 70kDa protein 1A
  • Activation of BAD and translocation to mitochondria
  • Inflammasomes
  • The NLRP1 inflammasome
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Programmed Cell Death
  • Activation of BH3-only proteins
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Innate Immune System
  • Intrinsic Pathway for Apoptosis
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • Viral RNP Complexes in the Host Cell Nucleus
  • Attenuation phase
  • Regulation of HSF1-mediated heat shock response
  • Cellular response to heat stress
  • AUF1 (hnRNP D0) destabilizes mRNA
  • Influenza Infection
  • Influenza Life Cycle
  • HSF1-dependent transactivation
  • Export of Viral Ribonucleoproteins from Nucleus
  • Ibuprofen
  • Paclitaxel
  • Docetaxel
  • Rasagiline
CACNA1A and RPL31 calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ribosomal protein L31
  • Integration of energy metabolism
  • Regulation of insulin secretion
  • Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels
  • Transmission across Chemical Synapses
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Pregabalin
  • Verapamil
  • Loperamide
  • Bepridil
CACNA1A and RPS17 calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ribosomal protein S17
  • Integration of energy metabolism
  • Regulation of insulin secretion
  • Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels
  • Transmission across Chemical Synapses
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Pregabalin
  • Verapamil
  • Loperamide
  • Bepridil

Page 10 out of 89 pages